MC2 Therapeutics CEO steps down as board member
After a research breakthrough, the Danish firm is ready to mature – meaning that Jesper J. Lange can’t both be chief executive and a board member.
by albert rønning-andersson, translated by daniel pedersen
Biotech company MC2 Therapeutics, which markets psoriasis cream Wynzora in the US and in Europe in collaboration with Epi Health and Almirall, recently chose to focus on its pipeline and on treating uremic pruritus after getting hands on good, new data.
Already a subscriber?Log in here
Read the whole article
Get access for 14 days for free. No credit card is needed, and you will not be automatically signed up for a paid subscription after the free trial.
With your free trial you get:
- Access all locked articles
- Receive our daily newsletters
- Access our app
.jpg&w=384&q=75)
